Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1089/SCD.2014.0058 | ||||
| Año | 2014 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The paired type homeobox 6 (Pax6) transcription factor (TF) regulates multiple aspects of neural stem cell (NSC) and neuron development in the embryonic central nervous system. However, less is known about the role of Pax6 in the maintenance and differentiation of adult NSCs and in adult neurogenesis. Using the +/Sey(Dey) mouse, we have analyzed how Pax6 heterozygosis influences the self-renewal and proliferation of adult olfactory bulb stem cells (aOBSCs). In addition, we assessed its influence on neural differentiation, neuronal incorporation, and cell death in the adult OB, both in vivo and in vitro. Our results indicate that the Pax6 mutation alters Nestin(+)-cell proliferation in vivo, as well as self-renewal, proliferation, and survival of aOBSCs in vitro although a subpopulation of +/Sey(Dey) progenitors is able to expand partially similar to wild-type progenitors. This mutation also impairs aOBSC differentiation into neurons and oligodendrocytes, whereas it increases cell death while preserving astrocyte survival and differentiation. Furthermore, Pax6 heterozygosis causes a reduction in the variety of neurochemical interneuron subtypes generated from aOBSCs in vitro and in the incorporation of newly generated neurons into the OB in vivo. Our findings support an important role of Pax6 in the maintenance of aOBSCs by regulating cell death, self-renewal, and cell fate, as well as in neuronal incorporation into the adult OB. They also suggest that deregulation of the cell cycle machinery and TF expression in aOBSCs which are deficient in Pax6 may be at the origin of the phenotypes observed in this adult NSC population.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Curto, Gloria G. | Mujer |
Hospital de Salamanca - España
Instituto de Neurociencias de Castilla y León - España Univ Salamanca - España |
| 2 | Nieto-Estevez, Vanesa | Mujer |
CSIC - España
Ctr Invest Biomed Red Enfermedades Neurodegenerat - España CSIC - Instituto Cajal (IC) - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 3 | Hurtado-Chong, Anahi | Mujer |
CSIC - España
CSIC - Instituto Cajal (IC) - España |
| 4 | Valero, Jorge | Hombre |
Hospital de Salamanca - España
Univ Coimbra - Portugal Instituto de Neurociencias de Castilla y León - España Universidade de Coimbra, Centro De Neurociências e Biologia Celular - Portugal Univ Salamanca - España University of Coimbra, Center for Neuroscience and Cell Biology - Portugal |
| 5 | GOMEZ-RODRIGUEZ, CARMELA | Mujer |
Hospital de Salamanca - España
Instituto de Neurociencias de Castilla y León - España Univ Salamanca - España |
| 6 | ALONSO-PENA, JOSE RAMON | Hombre |
Hospital de Salamanca - España
Universidad de Tarapacá - Chile Instituto de Neurociencias de Castilla y León - España Univ Salamanca - España |
| 7 | Weruaga, Eduardo | Hombre |
Hospital de Salamanca - España
Instituto de Neurociencias de Castilla y León - España Univ Salamanca - España |
| 8 | Vicario-Abejon, Carlos | Hombre |
CSIC - España
Ctr Invest Biomed Red Enfermedades Neurodegenerat - España CSIC - Instituto Cajal (IC) - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| Fuente |
|---|
| MINECO |
| Ministerio de Economía y Competitividad |
| MICINN |
| Ministerio de Ciencia y Tecnología |
| Spanish Ministerio de Ciencia e Innovación |
| FPI |
| Comunidad de Madrid |
| Ministerio de Economia y Competitividad (MINECO) |
| Instituto de Salud Carlos III (ISCIII) |
| Ministerio de Economia y Competitividad (MICINN) |
| Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Junta de Castilla y Leon, Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon y Fundacion Memoria D. Samuel Solorzano-Barruso |
| Red Olfativa Espanola |
| Agradecimiento |
|---|
| This work was funded by grants from the Spanish Ministerio de Ciencia e Innovacion and Ministerio de Economia y Competitividad (MICINN and MINECO; BFU2007-61230 and BFU2010-1963), the Instituto de Salud Carlos III (ISCIII; CIBERNED CB06/05/0065), and the Comunidad de Madrid (S2012/BMD-2336) to C.V.-A., and by grants from Ministerio de Ciencia y Tecnologia (BFU2010-18284), Ministerio de Sanidad, Politica Social e Igualdad (Plan Nacional Sobre Drogas), Junta de Castilla y Leon, Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon y Fundacion Memoria D. Samuel Solorzano-Barruso to J.R.A. and E.W. G.G.C., V.N.-E., and A.H.-C. were supported by a FPI. Fellowship from the MICINN and MINECO. G.G.C. was the recipient of a short-term fellowship from the Red Olfativa Espanola. |